Amgen Inc. buy Royal Bank of Canada
Start price
15.01.26
/
50%
€284.25
Target price
15.01.27
€287.83
Performance (%)
16.53%
Price
24.07.26
€330.70
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 16.53%. A total of €5.04 was paid as dividends for this prediction. This prediction currently runs until 15.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 3.295% | 3.295% |
| iShares Core DAX® | 0.855% | 1.375% |
| iShares Nasdaq 100 | -0.989% | -3.844% |
| iShares Nikkei 225® | -1.781% | -8.530% |
| iShares S&P 500 | 0.057% | 0.610% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $335.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat